NABUMETONE — all Canadian products
12 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NABUMETONE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02238639 | NABUMETONE | AA PHARMA INC | Tablet | Oral | NABUMETONE 500 MG | Marketed | |
| 02238369 | NABUMETONE | APOTEX INC | Tablet | Oral | NABUMETONE 500 MG | Approved | |
| 02244563 | MYLAN-NABUMETONE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | NABUMETONE 500 MG | Cancelled Post Market | |
| 02343282 | NABUMETONE | SANIS HEALTH INC | Tablet | Oral | NABUMETONE 500 MG | Cancelled Post Market | |
| 02239113 | NABUMETONE-500 | PRO DOC LIMITEE | Tablet | Oral | NABUMETONE 500 MG | Cancelled Post Market | |
| 02238759 | PMS-NABUMETONE | PHARMASCIENCE INC | Tablet | Oral | NABUMETONE 500 MG | Cancelled Pre Market | |
| 02238760 | PMS-NABUMETONE | PHARMASCIENCE INC | Tablet | Oral | NABUMETONE 750 MG | Cancelled Pre Market | |
| 02083531 | RELAFEN TABLETS 500MG | GLAXOSMITHKLINE INC | Tablet | Oral | NABUMETONE 500 MG | Cancelled Post Market | |
| 02083558 | RELAFEN TABLETS 750MG | GLAXOSMITHKLINE INC | Tablet | Oral | NABUMETONE 750 MG | Cancelled Post Market | |
| 02242912 | SANDOZ NABUMETONE | SANDOZ CANADA INCORPORATED | Tablet | Oral | NABUMETONE 500 MG | Cancelled Post Market | |
| 02240868 | TEVA-NABUMETONE | TEVA CANADA LIMITED | Tablet | Oral | NABUMETONE 750 MG | Cancelled Post Market | |
| 02240867 | TEVA-NABUMETONE | TEVA CANADA LIMITED | Tablet | Oral | NABUMETONE 500 MG | Cancelled Post Market |
Browse other molecules: